<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
<title>AI News 180m Report｜2026-11-05 18:00–21:00 JST｜Page 4 of 4</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html</link><description>One place for news and notices from 2 countries/regions: Taiwan, 184 items from 4 sources; Japan, 131 items from 1 source.One edition every 180 minutes: every item from every source received in the period, with the original link.</description><language>en</language>
<item><title>〈Hong Kong stocks after the close〉Tech and auto stocks surge across the board; Hang Seng Index jumps about 900 points, tech index soars more than 5%</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749214</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749214</guid><pubDate>Thu, 05 Nov 2026 17:42:05 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6648105">鉅亨網</source><description>Hong Kong stocks rebounded strongly Thursday (5日), with the Hang Seng Index gaining nearly 900 points and the tech index soaring more than 5%. Tech stocks including Alibaba, Tencent and Xiaomi rallied, while auto stocks also rose across the board. However, southbound Stock Connect recorded a net outflow of HK$21.3 billion.</description></item>
<item><title>〈Mainland stocks after the close〉Buying lifts Shanghai and ChiNext indexes; all 3 major indexes rise</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749215</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749215</guid><pubDate>Thu, 05 Nov 2026 17:30:03 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6647108">鉅亨網</source><description>China's 3 major A-share indexes opened lower Thursday (5日) before turning positive and moving higher. The Shanghai Composite, Shenzhen Component and ChiNext indexes closed up 0.1%, 1.19% and 0.87%, respectively, with turnover rising to RMB 2.1179 trillion. 華泰證券 and 國聯民生 said brokerage stocks are valued at low levels and offer allocation value, while investors should watch the quality of cash flows from AI computing power and applications in technology stocks.</description></item>
<item><title>U.S. midterm elections fuel AI regulatory concerns; tech selloff drags Nikkei down 1.66%</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749216</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749216</guid><pubDate>Thu, 05 Nov 2026 17:20:07 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6647980">鉅亨網</source><description>Japanese stocks fell Thursday as U.S. midterm elections fueled concerns about AI regulation, prompting a selloff in technology stocks that sent the Nikkei down 1.66% to a nearly 3-month low. In contrast, the TOPIX rebounded and closed up 1.2%, supported by traditional industries, leaving the 2 indexes sharply at odds.</description></item>
<item><title>Record high! Global DRAM revenue surges 369% in this year's Q3; Samsung leads with 38% share, SK海力士 widens lead over Micron</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749217</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749217</guid><pubDate>Thu, 05 Nov 2026 17:20:04 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6647979">鉅亨網</source><description>Global DRAM revenue hit a record, surging 369% in this year's Q3. Samsung led with a 38% market share, followed closely by SK海力士 at 29%, with Micron in third place at 21%. AI demand has made memory a scarce resource, and suppliers' results are expected to continue setting records.</description></item>
<item><title>中鋼 raises December prices slightly to stabilize supply-chain purchasing costs and expand orders</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749218</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749218</guid><pubDate>Thu, 05 Nov 2026 17:10:17 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6647973">鉅亨網</source><description>中鋼(2002-TW) announced a December price increase of NT$300 per metric ton, citing rising international steel prices, stronger export orders and exchange-rate factors. The move aims to stabilize supply-chain costs and expand orders.</description></item>
<item><title>Democrats’ sweeping victory sends U.S. stocks tumbling before a recovery; gold and silver rise as markets bet that “neither side can budge the other”</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749219</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749219</guid><pubDate>Thu, 05 Nov 2026 17:10:05 +0900</pubDate><category>Taiwan</category><source url="https://news.cnyes.com/news/id/6647627">鉅亨網</source><description>Democrats’ sweeping victory in the U.S. midterm elections, recapturing both chambers of Congress, triggered a global market reversal, with prices falling before rebounding. Markets are repricing the policy gridlock expected under a divided government, which is seen as limiting fiscal expansion and benefiting U.S. Treasuries, gold and silver, while regulatory concerns weigh on technology stocks in the short term.</description></item>
<item><title>2026-11-05 Institutional Trading: (Net buying) 晟德 404 lots, 美時 381 lots, 保瑞 334 lots; (Net selling) 松瑞藥 233 lots, 浩鼎 221 lots, 漢達 217 lots - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749647</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749647</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91115&amp;kind=20">環球生技月刊</source><description>Institutional trading activity on November 5, 2026: 晟德, 美時 and 保瑞 ranked as the top 3 net buys; 松瑞藥, 浩鼎 and 漢達 ranked as the top 3 net sells.</description></item>
<item><title>2026-11-05 Biotech Stocks: (Gainers) 科妍 9.97%, 康霈* 9.9%, 美時 5.66%; (Losers) 漢達 9.87%, 泰合 8.29%, 台新藥 7.95% - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749646</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749646</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91116&amp;kind=20">環球生技月刊</source><description>Biotech stock performance on November 5, 2026: 科妍 led with a 9.97% gain, while 漢達 led decliners with a 9.87% loss.</description></item>
<item><title>11/05 “Biotech Stock Update” - Global Bio &amp; Investment Monthly</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749645</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749645</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91117&amp;kind=20">環球生技月刊</source><description>The 11/05 biotech stock update covers capital increases and merger plans at companies including 安基生技 and 國璽幹細胞; 康霈 received China NMPA approval for a Phase I clinical trial. It also lists the day’s stock gains and losses and institutional net buying and selling.</description></item>
<item><title>精湛光學 (2070) posted consolidated profit of NT$106 million in the first three quarters of 115, with after-tax earnings of NT$2.62 per share - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749644</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749644</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91126&amp;kind=21">環球生技月刊</source><description>精湛光學 (2070) announced its consolidated financial report for the first three quarters of 115, reporting cumulative operating revenue of NT$601 million, pretax net profit of NT$124 million, net profit attributable to owners of the parent of NT$106 million, and basic earnings per share of NT$2.62.</description></item>
<item><title>國璽幹細胞 (6704) board approves simplified merger with subsidiary 啟安, with the tentative merger record date set for 115/12/31 - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749643</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749643</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91127&amp;kind=21">環球生技月刊</source><description>國璽幹細胞應用技術股份有限公司（6704）董事會決議與100%持股子公司啟安國際生醫投資股份有限公司進行簡易合併，暫定合併基準日為115年12月31日，旨在精簡管理費用及成本。</description></item>
<item><title>國璽幹細胞 (6704) board approves simplified merger with subsidiary 啟安; creditor objection period runs from 11/6 to 12/30 - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749642</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749642</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91128&amp;kind=21">環球生技月刊</source><description>國璽幹細胞 (6704) subsidiary 啟安國際生醫投資股份有限公司, following a board resolution, will carry out a simplified merger with its parent company. The tentative merger record date is December 31, 115, and the creditor objection period runs from November 6 to December 30, 115.</description></item>
<item><title>國璽幹細胞 (6704): Subsidiary 啟安 to merge with parent company in a simplified merger; tentative merger record date 115/12/31 - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749641</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749641</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91129&amp;kind=21">環球生技月刊</source><description>國璽幹細胞 (6704) announced that its subsidiary 啟安國際生醫投資股份有限公司 will carry out a simplified merger with its parent company, with the tentative merger record date set for 115/12/31. The move aims to reduce management expenses and costs.</description></item>
<item><title>安基生技 (7754) plans capital increase of 14 million shares at NT$60 per share; record date 12/6 - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749640</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749640</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91130&amp;kind=21">環球生技月刊</source><description>安基生技 (7754) announced a cash capital increase of 14 million shares at an issue price of NT$60 per share. The subscription record date is set for December 6, 115, and the proceeds will be used to strengthen working capital.</description></item>
<item><title>安基生技 (7754) plans capital increase of 14 million shares at NT$60 per share; record date 12/6 - 環球生技月刊</title><link>https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749630</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261105-18/index-en-p4.html#n3749630</guid><pubDate>Thu, 05 Nov 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=91130&amp;range=news">環球生技月刊</source><description>安基生技 (7754) announced a cash capital increase, issuing 14 million shares at a subscription price of NT$60 per share. The record date is set for December 6, 115, and the proceeds will be used to strengthen working capital.</description></item>
</channel></rss>
